Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription


3 Arthritis Res Ther
4 Clin Exp Rheumatol
5 Clin Rheumatol
2 Rheumatol Int

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Arthritis Res Ther

  1. KNITZA J, Tascilar K, Vuillerme N, Eimer E, et al
    Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients-results from a randomized controlled trial.
    Arthritis Res Ther. 2022;24:125.
    PubMed         Abstract available

  2. SHI L, Wang J, Guo HX, Han XL, et al
    Circulating Th2 cell reduction and Th1/Th2 imbalance are correlated with primary Sjogren's syndrome-associated interstitial lung disease.
    Arthritis Res Ther. 2022;24:121.
    PubMed         Abstract available

  3. HERTRAMPF S, Klotsche J, Schefer Q, Glimm AM, et al
    Monitoring of patients with rheumatoid arthritis by indocyanine green (ICG)-enhanced fluorescence optical imaging treated with anti-TNFalpha therapy.
    Arthritis Res Ther. 2022;24:117.
    PubMed         Abstract available

    Clin Exp Rheumatol

  4. LEE H, Chen SK, Gautam N, Vine SM, et al
    Risk of malignant melanoma and non-melanoma skin cancer in rheumatoid arthritis patients initiating methotrexate versus hydroxychloroquine: a cohort study.
    Clin Exp Rheumatol. 2022 May 10. pii: 18274.
    PubMed         Abstract available

  5. BALDINI C, Arnaud L, Avcin T, Beretta L, et al
    Sjogren's syndrome and other rare and complex connective tissue diseases: an intriguing liaison.
    Clin Exp Rheumatol. 2022;40 Suppl 134:103-112.
    PubMed         Abstract available

  6. MUCKE J, Cornet A, Witte T, Schneider M, et al
    Association of common variable immunodeficiency and rare and complex connective tissue and musculoskeletal diseases. A systematic literature review.
    Clin Exp Rheumatol. 2022;40 Suppl 134:40-45.
    PubMed         Abstract available

  7. PETITDEMANGE A, Sztejkowski C, Damian L, Martin T, et al
    Treatment of relapsing polychondritis: a systematic review.
    Clin Exp Rheumatol. 2022;40 Suppl 134:81-85.
    PubMed         Abstract available

    Clin Rheumatol

  8. EZEANUNA MN, Prince DK, Alexander SA, Richards JS, et al
    Association of rheumatoid arthritis with mortality in chronic kidney disease: a cohort study.
    Clin Rheumatol. 2022 May 25. pii: 10.1007/s10067-022-06223.
    PubMed         Abstract available

  9. PHATAK S, Khenat A, Malandkar M, Amin S, et al
    Real-world evidence of the effectiveness and safety of generic tofacitinib in rheumatoid arthritis patients: a retrospective, single-centre analysis from Western India.
    Clin Rheumatol. 2022 May 21. pii: 10.1007/s10067-022-06205.
    PubMed         Abstract available

  10. ZHAI X, Wang Y, Guo H, Liang Z, et al
    Altered levels of circulating CD8(+)CXCR5(+)PD-1(+)T follicular cytotoxic cells in primary Sjogren's syndrome.
    Clin Rheumatol. 2022;41:1697-1708.
    PubMed         Abstract available

  11. YANG Y, Yuan X, Wang X, Tao R, et al
    Preliminary MRI-based investigation of characteristics and prognosis of knee bone marrow edema in children with juvenile idiopathic arthritis.
    Clin Rheumatol. 2022;41:1793-1799.
    PubMed         Abstract available

  12. GIESEN T, Sanduleanu S, Jansen TLTA
    Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study.
    Clin Rheumatol. 2022;41:1833-1841.
    PubMed         Abstract available

    Rheumatol Int

  13. POPOVA V, Geneva-Popova M, Kraev K, Batalov A, et al
    Assessment of TNF-alpha expression in unstable atherosclerotic plaques, serum IL-6 and TNF-alpha levels in patients with acute coronary syndrome and rheumatoid arthritis.
    Rheumatol Int. 2022 May 26. pii: 10.1007/s00296-022-05113.
    PubMed         Abstract available

  14. ZEKIC T, Benic MS, Radic M
    Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease.
    Rheumatol Int. 2022 May 23. pii: 10.1007/s00296-022-05143.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.